Role of MS Disease Modifying Therapy in Concomitant Oncologic Immune Checkpoint Inhibitor Treatment

被引：0
|
作者：
Siddiqui, A. [1 ]
Hersh, C. M. [1 ]
Hua, L. H. [1 ]
机构：
[1] Cleveland Clin LRCBH, Las Vegas, NV USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P424
引用
收藏
页码：214 / 215
页数：2
相关论文
共 50 条
  • [1] Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association?
    Hussain, Nadiya
    Naeem, Muntaha
    Pinato, David J.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (01) : 55 - 61
  • [2] Concomitant myopericarditis and takotsubo syndrome following immune checkpoint inhibitor therapy
    Tan, Nicholas Yick Loong
    Anavekar, Nandan S.
    Wiley, Brandon M.
    BMJ CASE REPORTS, 2020, 13 (09)
  • [3] The prognostic role of lymphocyte count for treatment response in immune checkpoint inhibitor therapy
    Conroy, M.
    O'Sullivan, H.
    Collins, D.
    Bambury, R.
    Power, D. G.
    Grossman, S.
    O'Reilly, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S289 - S289
  • [4] Therapy: Rheumatic disease after immune checkpoint inhibitor therapy
    Ummarino D.
    Nature Reviews Rheumatology, 2017, 13 (8) : 450 - 450
  • [5] The role of gut microbiota in immune checkpoint inhibitor therapy
    Yi, Ming
    Qin, Shuang
    Chu, Qian
    Wu, Kongming
    HEPATOBILIARY SURGERY AND NUTRITION, 2018, 7 (06) : 481 - 483
  • [6] Immune Checkpoint Inhibitor Therapy in Patients With Autoimmune Disease
    Johnson, Douglas B.
    Beckermann, Kathryn E.
    Wang, Daniel Y.
    ONCOLOGY-NEW YORK, 2018, 32 (04): : 190 - 194
  • [7] Concomitant Primary and Secondary Adrenal Insufficiency due to Immune Checkpoint Inhibitor Therapy
    Montalvan, Eileen
    Pasha, Mohammed Afraz
    Jackson, Bethany
    SOUTHERN MEDICAL JOURNAL, 2022, 115 (07) : 548 - 549
  • [8] Subclinical Celiac Disease Unmasked by Immune Checkpoint Inhibitor Therapy
    Braun, David S.
    Patel, Shruti
    Schwartz, Armond
    JOURNAL OF IMMUNOTHERAPY, 2023, 46 (04) : 152 - 153
  • [9] Does immune checkpoint inhibitor therapy increase the frequency of adverse reactions to concomitant medications?
    Hammond, Sean
    Olsson-Brown, Anna
    Grice, Sophie
    Naisbitt, Dean J.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (05): : 600 - 603
  • [10] Ocular surface disease associated with immune checkpoint inhibitor therapy
    Park, Royce B.
    Jain, Sandeep
    Han, Hui
    Park, Jennifer
    OCULAR SURFACE, 2021, 20 : 115 - 129
12345